ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 905,10
-0,26%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. (MM) (PCYC)

  7. (MM) (PCYC) Actualités

PCYC

(MM) (PCYC)

(MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PCYC
DateHeureSourceTitreSymboleSociété
15/06/201521h02Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PCYC(MM)
10/06/201518h51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PCYC(MM)
05/06/201513h01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:PCYC(MM)
01/06/201517h24Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PCYC(MM)
31/05/201515h05PR Newswire (US)Ibrutinib (IMBRUVICA®) Phase Ib/II Data Show Promise in Patients with Chronic Graft-Versus-Host-DiseaseNASDAQ:PCYC(MM)
30/05/201513h31PR Newswire (US)Phase III HELIOS Study Results Show Ibrutinib (IMBRUVICA®) Combination Therapy Significantly Increased Progression-Free Surv...NASDAQ:PCYC(MM)
29/05/201501h26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201515h00PR Newswire (US)Ibrutinib (IMBRUVICA®) in Combination with Anti-PD-L1 Antibody (MEDI4736) Study Commences for Patients with Two Relapsed/Ref...NASDAQ:PCYC(MM)
26/05/201514h48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCYC(MM)
26/05/201514h48Edgar (US Regulatory)(25-NSE)NASDAQ:PCYC(MM)
26/05/201514h40Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PCYC(MM)
26/05/201513h35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201513h10Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:PCYC(MM)
22/05/201514h04PR Newswire (US)European Medicines Agency Issues Positive Opinion, Recommends Full Approval of IMBRUVICA® (ibrutinib) to Treat Waldenstrom's...NASDAQ:PCYC(MM)
20/05/201516h06The Motley FoolSWOT Analysis of Gilead Sciences Inc. StockNASDAQ:PCYC(MM)
14/05/201514h58Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PCYC(MM)
13/05/201523h21PR Newswire (US)New ibrutinib (IMBRUVICA®) Data to be Showcased at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:PCYC(MM)
05/05/201523h56Dow Jones NewsAbbVie Wraps Up Large Debt Sale for Pharmacyclics DealNASDAQ:PCYC(MM)
05/05/201523h38Dow Jones NewsAbbVie Wraps Up Large Debt Sale For Pharmacyclics DealNASDAQ:PCYC(MM)
05/05/201520h40Dow Jones NewsAbbVie Launches Large Debt Sale for Pharmacyclics DealNASDAQ:PCYC(MM)
05/05/201515h38Analyst Ratings NetworkZacks Lowers Pharmacyclics to Hold (PCYC)NASDAQ:PCYC(MM)
04/05/201523h09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PCYC(MM)
04/05/201516h27Analyst Ratings NetworkPharmacyclics Lifted to "Buy" at Zacks (PCYC)NASDAQ:PCYC(MM)
02/05/201500h58Dow Jones NewsAbbVie Extends Exchange Offer to Acquire PharmacyclicsNASDAQ:PCYC(MM)
01/05/201515h15PR Newswire (US)Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business UpdatesNASDAQ:PCYC(MM)
23/04/201520h44Dow Jones NewsAbbVie Profit Rises on Broad Sales Growth -- UpdateNASDAQ:PCYC(MM)
23/04/201519h12Dow Jones NewsAbbVie Profit Rises 4.3%NASDAQ:PCYC(MM)
23/04/201519h08Dow Jones NewsAbbVie Profit Rises 4.3% on Broad Sales GrowthNASDAQ:PCYC(MM)
23/04/201517h34The Motley FoolHumira Propels AbbVie Inc. to a Solid First QuarterNASDAQ:PCYC(MM)
20/04/201518h16Analyst Ratings NetworkBMO Capital Markets Reiterates "Positive" Rating for Pharmacyclics (PCYC)NASDAQ:PCYC(MM)
 Showing the most relevant articles for your search:NASDAQ:PCYC

Dernières Valeurs Consultées

BIT
UC3JSE
Unicredit Bank
BIT
F37915
Vontobel Financial Produ...
GATE
SMURFCATUSDT
Real Smurf Cat
LSE
AF13
Citi Fun 25
NASDAQ
TPST
Tempest Therpeutics
LSE
AT39
Citi Fun 32
LSE
0A2O
Lyft
BIT
UC5GUR
Unicredit Bank
UNSW
XRTETH
Robonomics
LSE
TU32
Citi Fun 25
LSE
PA28
Citi Fun 24
BIT
UB3JRC
UniCredit Bank
COIN
BTSETH
BitShares
LSE
AP37
Citi Fun 24
NASDAQ
MACQ
MCAP Acquisition
LSE
NZ55
Citi Fun 23
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés